One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients (vol 11, e023454, 2022)

被引：0
|
作者：
Pivato
机构：
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2022年 / 11卷 / 16期
关键词：
D O I：
10.1161/JAHA.121.020787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 48 条
  • [1] One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients
    Pivato, Carlo A.
    Reimers, Bernhard
    Testa, Luca
    Pacchioni, Andrea
    Briguori, Carlo
    Musto, Carmine
    Esposito, Giovanni
    Piccolo, Raffaele
    Lucisano, Luigi
    De Luca, Leonardo
    Conrotto, Federico
    De Marco, Andrea
    Franzone, Anna
    Presbitero, Patrizia
    Ferrante, Giuseppe
    Condorelli, Gerolama
    Paradies, Valeria
    Sardella, Gennaro
    Indolfi, Ciro
    Condorelli, Gianluigi
    Stefanini, Giulio G.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [2] One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents
    Musto, Carmine
    Paolucci, Luca
    Pivato, Carlo Andrea
    Testa, Luca
    Pacchioni, Andrea
    Briguori, Carlo
    Esposito, Giovanni
    Piccolo, Raffaele
    Lucisano, Luigi
    De Luca, Leonardo
    Conrotto, Federico
    Sanz-Sanchez, Jorge
    Cesario, Vincenzo
    De Felice, Francesco
    Latini, Alessia Chiara
    Regazzoli, Damiano
    Sardella, Gennaro
    Indolfi, Ciro
    Reimers, Bernhard
    Condorelli, Gianluigi
    Stefanini, Giulio
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 207 : 170 - 178
  • [3] One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
    Kandzari, David E.
    Kirtane, Ajay J.
    Windecker, Stephan
    Latib, Azeem
    Kedhi, Elvin
    Mehran, Roxana
    Price, Matthew J.
    Abizaid, Alexandre
    Simon, Daniel I.
    Worthley, Stephen G.
    Zaman, Azfar
    Choi, James W.
    Caputo, Ronald
    Kanitkar, Mihir
    McLaurin, Brent
    Potluri, Srinivasa
    Smith, Timothy
    Spriggs, Douglas
    Tolleson, Thaddeus
    Nazif, Tamim
    Parke, Maria
    Lee, Lilian C.
    Lung, Te-Hsin
    Stone, Gregg W.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (11) : E009565
  • [4] Three-year clinical outcomes after six-month versus twelve-month dual antiplatelet therapy in patients with everolimus-eluting and sirolimus-eluting stents
    Shin, D. -H.
    Park, K. W.
    Kim, J. S.
    Kim, B. K.
    Ko, Y. G.
    Choi, D.
    Hong, M. K.
    Gwon, H. C.
    Kim, H. S.
    Jang, Y.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 29 - 29
  • [5] One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk
    Pivato, C. A.
    Musto, C.
    Paolucci, L.
    Testa, L.
    Pacchioni, A.
    Briguori, C.
    Esposito, G.
    Lucisano, L.
    De Luca, L.
    Latini, A. C.
    Regazzoli, D.
    Sardella, G.
    Indolfi, C.
    Condorelli, G.
    Stefanini, G. G.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [6] One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease
    Mankerious, Nader
    Toelg, Ralph
    Vogel, Birgit
    Sartori, Samantha
    Angiolillo, Dominick J.
    Vranckx, Pascal
    Feng, Yihan
    Hernandez, Jose M. de la Torre
    Krucoff, Mitchell W.
    Bhatt, Deepak L.
    Spirito, Alessandro
    Cao, Davide
    Chehab, Bassem M.
    Kunadian, Vijay
    Maksoud, Aziz
    Picon, Hector
    Sardella, Gennaro
    Thiele, Holger
    Varenne, Olivier
    Windecker, Stephan
    Richardt, Gert
    Valgimigli, Marco
    Mehran, Roxana
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 225 : 25 - 34
  • [7] Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial
    Rubbio, Antonio Popolo
    Testa, Luca
    Pivato, Carlo A.
    Regazzoli, Damiano
    Piccolo, Raffaele
    Esposito, Giovanni
    Musto, Carmine
    Scalia, Lorenzo
    Pacchioni, Andrea
    Briguori, Carlo
    Lucisano, Luigi
    De Luca, Leonardo
    Conrotto, Federico
    Tartaglia, Francesco
    Latini, Alessia C.
    Stankowski, Kamil
    Chiarito, Mauro
    Sardella, Gennaro
    Indolfi, Ciro
    Bedogni, Francesco
    Reimers, Bernhard
    Condorelli, Gianluigi
    Stefanini, Giulio G.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 67 : 77 - 83
  • [8] Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent
    Yoon, Yong-Hoon
    Park, Gyung-Min
    Roh, Jae-Hyung
    Her, Sung-Ho
    Lim, Seong-Hoon
    Kang, Tae Soo
    Lee, Seung Jin
    Bae, Jang-Whan
    Choi, WoongGil
    Yang, Yong-Mo
    Kim, Junghee
    Choi, Yu Jeong
    Choi, Si Wan
    Lee, Jae-Hwan
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2022, 2022
  • [9] Primary Results of the EVOLVE Short DAPT Study Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent
    Kirtane, Ajay J.
    Stoler, Robert
    Feldman, Robert
    Neumann, Franz-Josef
    Boutis, Loukas
    Tahirkheli, Naeem
    Toelg, Ralph
    Othman, Islam
    Stein, Bernardo
    Choi, James W.
    Windecker, Stephan
    Yeh, Robert W.
    Dauerman, Harold L.
    Price, Matthew J.
    Underwood, Paul
    Allocco, Dominic
    Meredith, Ian
    Kereiakes, Dean J.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (03) : E010144
  • [10] Initial Experience of Bioabsorbable Polymer Everolimus-Eluting Synergy Stents in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention With Early Discontinuation of Dual-Antiplatelet Therapy
    Noad, Rebecca L.
    Hanratty, Colm G.
    Walsh, Simon J.
    [J]. JOURNAL OF INVASIVE CARDIOLOGY, 2017, 29 (02): : 36 - 41
12345